VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $237,782,000 | -45.8% | 1,333,014 | -32.6% | 0.37% | -42.9% |
| Q2 2015 | $439,036,000 | -7.5% | 1,976,306 | -17.3% | 0.66% | -7.4% |
| Q1 2015 | $474,455,000 | +42.5% | 2,388,757 | +2.7% | 0.71% | +36.8% |
| Q4 2014 | $332,937,000 | +12.2% | 2,326,449 | +2.9% | 0.52% | +2.8% |
| Q3 2014 | $296,733,000 | +7.0% | 2,261,683 | +2.8% | 0.50% | +7.9% |
| Q2 2014 | $277,395,000 | +7.6% | 2,199,452 | +12.5% | 0.47% | +1.3% |
| Q1 2014 | $257,767,000 | +14.0% | 1,955,301 | +1.5% | 0.46% | +9.0% |
| Q4 2013 | $226,176,000 | +14.9% | 1,926,544 | +2.1% | 0.42% | +3.7% |
| Q3 2013 | $196,882,000 | +31.1% | 1,887,105 | +8.1% | 0.41% | +22.2% |
| Q2 2013 | $150,214,000 | – | 1,745,053 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |